Cite
HARVARD Citation
Mozaffarian, N. et al. (2013). AB0188 Combination therapy with adalimumab plus methotrexate reduces circulating levels of pro-matrix matalloproteinases-1 and -3 independently of clinical disease activity in patients with rheumatoid arthritis. Annals of the rheumatic diseases. p. A843. [Online].